---
figid: PMC8724284__41392_2021_762_Fig1_HTML
figtitle: 'Wnt/Beta-catenin signalling: function, biological mechanisms, and therapeutic
  opportunities'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8724284
filename: 41392_2021_762_Fig1_HTML.jpg
figlink: /pmc/articles/PMC8724284/figure/Fig1/
number: F1
caption: 'Wnt/β-catenin pathway. Left (inactivation of Wnt signalling): In the absence
  of Wnt signalling, β-catenin is degraded by protein complexes, including AXIN, APC,
  serine/threonine kinase GSK-3, and CK1 and E3 ubiquitin ligase β-trcp. Right (activation
  of Wnt signalling): Wnt signalling is activated by binding to its receptor, which
  induces the binding of AXIN to phosphorylated lipoprotein receptor-related protein
  (LRP). The destruction complex is broken, and then β-catenin stabilizes and binds
  to TCF in the nucleus to regulate the target gene. GSK-3 glycogen synthase kinase-3,
  AXIN axis inhibition protein, CK1 casein kinase 1, APC adenomatous polyposis coli,
  TCF T cell factor, LEF lymphocyte enhancer factor-1'
papertitle: 'Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic
  opportunities.'
reftext: Jiaqi Liu, et al. Signal Transduct Target Ther. 2022;7:3.
year: '2022'
doi: 10.1038/s41392-021-00762-6
journal_title: Signal Transduction and Targeted Therapy
journal_nlm_ta: Signal Transduct Target Ther
publisher_name: Nature Publishing Group UK
keywords: Oncogenes | Drug regulation | Cancer genetics | Non-coding RNAs | Self-renewal
automl_pathway: 0.9541786
figid_alias: PMC8724284__F1
figtype: Figure
redirect_from: /figures/PMC8724284__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8724284__41392_2021_762_Fig1_HTML.html
  '@type': Dataset
  description: 'Wnt/β-catenin pathway. Left (inactivation of Wnt signalling): In the
    absence of Wnt signalling, β-catenin is degraded by protein complexes, including
    AXIN, APC, serine/threonine kinase GSK-3, and CK1 and E3 ubiquitin ligase β-trcp.
    Right (activation of Wnt signalling): Wnt signalling is activated by binding to
    its receptor, which induces the binding of AXIN to phosphorylated lipoprotein
    receptor-related protein (LRP). The destruction complex is broken, and then β-catenin
    stabilizes and binds to TCF in the nucleus to regulate the target gene. GSK-3
    glycogen synthase kinase-3, AXIN axis inhibition protein, CK1 casein kinase 1,
    APC adenomatous polyposis coli, TCF T cell factor, LEF lymphocyte enhancer factor-1'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - 'Off'
  - arr
  - sgg
  - arm
  - Axn
  - pan
  - fz
  - Apc
  - Apc2
  - Fs(3)Apc
  - 'On'
  - oo
  - CkIalpha
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - CTNNB1
  - AXIN1
  - AXIN2
  - HNF4A
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - IGKV3D-20
  - APC
  - PROC
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - CSNK1A1
---
